Zhejiang Jingxin Pharmaceutical Statistics

Total Valuation

Zhejiang Jingxin Pharmaceutical has a market cap or net worth of CNY 10.69 billion. The enterprise value is 9.94 billion.

Market Cap	10.69B
Enterprise Value	9.94B

Important Dates

The next estimated earnings date is Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	May 24, 2024

Share Statistics

Zhejiang Jingxin Pharmaceutical has 861.03 million shares outstanding. The number of shares has decreased by -0.25% in one year.

Shares Outstanding	861.03M
Shares Change (YoY)	-0.25%
Shares Change (QoQ)	-0.11%
Owned by Insiders (%)	24.74%
Owned by Institutions (%)	16.96%
Float	513.05M

Valuation Ratios

The trailing PE ratio is 15.14 and the forward PE ratio is 15.63.

PE Ratio	15.14
Forward PE	15.63
PS Ratio	2.54
PB Ratio	1.89
P/FCF Ratio	19.56
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.32, with an EV/FCF ratio of 18.19.

EV / Earnings	14.09
EV / Sales	2.36
EV / EBITDA	11.32
EV / EBIT	15.89
EV / FCF	18.19

Financial Position

The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.09.

Current Ratio	1.24
Quick Ratio	0.86
Debt / Equity	0.09
Debt / EBITDA	0.56
Debt / FCF	0.90
Interest Coverage	70.09

Financial Efficiency

Return on equity (ROE) is 13.02% and return on invested capital (ROIC) is 6.61%.

Return on Equity (ROE)	13.02%
Return on Assets (ROA)	4.88%
Return on Capital (ROIC)	6.61%
Revenue Per Employee	1.08M
Profits Per Employee	180,378
Employee Count	3,909
Asset Turnover	0.53
Inventory Turnover	2.91

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +6.65% in the last 52 weeks. The beta is 0.13, so Zhejiang Jingxin Pharmaceutical's price volatility has been lower than the market average.

Beta (5Y)	0.13
52-Week Price Change	+6.65%
50-Day Moving Average	11.15
200-Day Moving Average	11.12
Relative Strength Index (RSI)	61.36
Average Volume (20 Days)	13,926,421

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Zhejiang Jingxin Pharmaceutical had revenue of CNY 4.21 billion and earned 705.10 million in profits. Earnings per share was 0.82.

Revenue	4.21B
Gross Profit	2.14B
Operating Income	625.25M
Pretax Income	823.18M
Net Income	705.10M
EBITDA	865.36M
EBIT	625.25M
Earnings Per Share (EPS)	0.82

Full Income Statement

Balance Sheet

The company has 1.27 billion in cash and 493.00 million in debt, giving a net cash position of 778.43 million or 0.90 per share.

Cash & Cash Equivalents	1.27B
Total Debt	493.00M
Net Cash	778.43M
Net Cash Per Share	0.90
Equity (Book Value)	5.69B
Book Value Per Share	6.57
Working Capital	580.30M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 855.83 million and capital expenditures -309.57 million, giving a free cash flow of 546.26 million.

Operating Cash Flow	855.83M
Capital Expenditures	-309.57M
Free Cash Flow	546.26M
FCF Per Share	0.63

Full Cash Flow Statement

Margins

Gross margin is 50.81%, with operating and profit margins of 14.84% and 16.74%.

Gross Margin	50.81%
Operating Margin	14.84%
Pretax Margin	19.54%
Profit Margin	16.74%
EBITDA Margin	20.54%
EBIT Margin	14.84%
FCF Margin	12.97%

Dividends & Yields

This stock pays an annual dividend of 0.30, which amounts to a dividend yield of 2.36%.

Dividend Per Share	0.30
Dividend Yield	2.36%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	36.63%
Buyback Yield	0.25%
Shareholder Yield	2.61%
Earnings Yield	6.60%
FCF Yield	5.11%

Dividend Details

Stock Splits

The last stock split was on May 28, 2021. It was a forward split with a ratio of 1.2.

Last Split Date	May 28, 2021
Split Type	Forward
Split Ratio	1.2

Scores

Zhejiang Jingxin Pharmaceutical has an Altman Z-Score of 3.52.

Altman Z-Score	3.52
Piotroski F-Score	n/a